Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.
For more information, visit tempus.com.
RadNet, Inc. is the largest U.S. provider of freestanding outpatient diagnostic imaging services, operating over 400 centers across key markets, including Arizona, California, Florida, and New York. In addition to imaging, RadNet offers AI-driven solutions under the DeepHealth brand, radiology IT, and teleradiology services. With over 10,000 employees and affiliated radiologists, RadNet is dedicated to advancing healthcare through innovation and expertise.
Lunit is a leading provider of AI solutions for cancer diagnostics and therapeutics, with a mission to conquer cancer through AI.
Our clinically proven AI enables healthcare providers to detect cancer earlier, make more precise treatment decisions, and improve patient outcomes — transforming how cancer is diagnosed and treated.
Our technology spans the entire cancer continuum, from risk prediction and screening optimization to early detection and precision oncology.
Lunit’s breast and chest imaging AI boosts diagnostic accuracy and efficiency, while our pathology AI is leveraged by leading pharmaceutical companies to drive biomarker discovery and companion diagnostics (CDx) development.
Trusted by 10,000+ sites across 65+ countries,
Lunit continues to redefine global standards in data-driven cancer care.
Learn more about our technology and mission at www.lunit.io/en